Salivary Nitrate Level and Lipid Profile in Patients with Hypertension: A Cross-Sectional Study in a Saudi Sub-Population
Authors:
- Khalil Ibrahim AssiriKAKhalil Ibrahim Assiri
- Ali Mosfer A. AlqahtaniAAAli Mosfer A. Alqahtani
- Abdullah AlqarniAAAbdullah Alqarni
- Hassan Ahmed AssiriHassan Ahmed Assiri
- Saeed AlassiriSASaeed Alassiri
- Samiunnisa Begum ShaikSSSamiunnisa Begum Shaik
- Ali Azhar DawasazADAli Azhar Dawasaz
- Mohammad Shahul HameedMHMohammad Shahul Hameed
Open Access
- 22 November 2024
- journal article
- research article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 13 (23) , 7051
Abstract
Background: The use of salivary biomarkers offers a non-invasive approach to understanding the metabolic and inflammatory status of hypertensive patients. This study aimed to quantify the salivary nitric oxide (NO), total cholesterol, triglycerides, high-density lipoproteins (HDL), and low-density lipoproteins (LDL) levels in hypertensive individuals and healthy controls in a sub-population in Saudi Arabia. Methods: This cross-sectional study comprised 40 hypertensive patients (test group, 40–50 years old) and 40 age-matched healthy controls who visited the dental hospital in the College of Dentistry, King Khalid University, for dental treatment. Nitric oxide, total cholesterol, triglycerides, HDL, and LDL levels in saliva were assessed. An independent sample t-test was used to compare the results between the hypertensive and control groups. Results: The mean triglyceride and cholesterol levels in the test group were significantly higher (p < 0.05) than those in the control group. Alternatively, the NO level in the test group was significantly (p = 0.014) lower than that in the controls. The triglyceride level was significantly correlated with age in the test group (p = 0.04). Conclusions: This study demonstrated significant differences in the nitrate levels and lipid profiles between hypertensive patients and healthy individuals in a sub-population in Saudi Arabia. The findings indicate that saliva can be used as a non-invasive diagnostic tool for assessing nitrate levels and the lipid profile. However, additional studies with larger sample sizes and more precise testing parameters are required to validate the findings.Keywords
All Related Versions
Funding Information
- King Khalid University (RGP1/86/45)
This publication has 34 references indexed in Scilit:
- The Effect of Dietary Nitrate on the Oral Microbiome and Salivary Biomarkers in Individuals with High Blood PressureThe Journal of Nutrition, 2024
- Nitrate reduction capacity of the oral microbiota is impaired in periodontitis: potential implications for systemic nitric oxide availabilityInternational Journal of Oral Science, 2024
- Nitric oxide deficiency is a primary driver of hypertensionBiochemical Pharmacology, 2022
- Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participantsThe Lancet, 2021
- Association between hypertension, oral microbiome and salivary nitric oxide: A case-control studyNitric Oxide, 2021
- Production and physiological role of NO in the oral cavityJapanese Dental Science Review, 2016
- Physiological role for nitrate-reducing oral bacteria in blood pressure controlFree Radical Biology and Medicine, 2013
- The nitrate–nitrite–nitric oxide pathway in physiology and therapeuticsNature Reviews Drug Discovery, 2008
- Nitrate and nitrite concentrations in human saliva: Variations with salivary flow-rateFood and Chemical Toxicology, 1989
- Cholesterol metabolism and agingThe American Journal of Medicine, 1987